dexmedetomidine has been researched along with tyramine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dinenno, FA; Kirby, BS; Markwald, RR; Smith, EG; Voyles, WF | 1 |
| Donato, AJ | 1 |
1 review(s) available for dexmedetomidine and tyramine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for dexmedetomidine and tyramine
| Article | Year |
|---|---|
Ageing and leg postjunctional alpha-adrenergic vasoconstrictor responsiveness in healthy men.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adult; Aged; Aging; Blood Flow Velocity; Dexmedetomidine; Dose-Response Relationship, Drug; Femoral Artery; Humans; Laser-Doppler Flowmetry; Leg; Male; Middle Aged; Norepinephrine; Phenylephrine; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Reference Values; Research Design; Sympathetic Nervous System; Tyramine; Vasoconstriction; Vasoconstrictor Agents | 2007 |
Ageing and vascular adrenoceptor desensitization: too little, too late?
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adult; Aged; Aging; Blood Flow Velocity; Dexmedetomidine; Femoral Artery; Humans; Leg; Male; Middle Aged; Norepinephrine; Phenylephrine; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Reference Values; Sympathetic Nervous System; Tyramine; Vasoconstriction; Vasoconstrictor Agents | 2007 |